Laboratory Corporation of America Holdings [NYSE: LH] closed the trading session at $174.26 on 08/27/20. The day’s price range saw the stock hit a low of $170.05, while the highest price level was $178.21.
The stocks have a year to date performance of 3.01 percent and weekly performance of -4.08 percent. The stock has been moved at -0.81 percent over the last six months. The stock has performed -10.46 percent around the most recent 30 days and changed -0.60 percent over the most recent 3-months.
If compared to the average trading volume of 793.85K shares, LH reached to a volume of 2685985 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Laboratory Corporation of America Holdings [LH]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for LH shares is $228.57 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on LH stock is a recommendation set at 1.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BofA Securities have made an estimate for Laboratory Corporation of America Holdings shares, keeping their opinion on the stock as Buy, with their previous recommendation back on July 14, 2020. The new note on the price target was released on July 13, 2020, representing the official price target for Laboratory Corporation of America Holdings stock. Previously, the target price had yet another raise to $210, while Deutsche Bank analysts kept a Buy rating on LH stock. On May 15, 2020, analysts increased their price target for LH shares from 158 to 186.
The Average True Range (ATR) for Laboratory Corporation of America Holdings is set at 4.70, with the Price to Sales ratio for LH stock in the period of the last 12 months amounting to 1.49. The Price to Book ratio for the last quarter was 2.31, with the Price to Cash per share for the same quarter was set at 5.69. Price to Free Cash Flow for LH in the course of the last twelve months was 14.54 with Quick ratio for the last quarter at 1.00.
LH stock trade performance evaluation
Laboratory Corporation of America Holdings [LH] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -4.08. With this latest performance, LH shares dropped by -10.46% in over the last four-week period, additionally sinking by -0.81% over the last 6 months – not to mention a rise of 6.11% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for LH stock in for the last two-week period is set at 33.42, with the RSI for the last a single of trading hit 21.12, and the three-weeks RSI is set at 39.07 for Laboratory Corporation of America Holdings [LH]. The present Moving Average for the last 50 days of trading for this stock 182.39, while it was recorded at 178.56 for the last single week of trading, and 169.82 for the last 200 days.
Laboratory Corporation of America Holdings [LH]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Laboratory Corporation of America Holdings [LH] shares currently have an operating margin of +12.46 and a Gross Margin at +26.04. Laboratory Corporation of America Holdings’s Net Margin is presently recorded at +7.13.
Return on Total Capital for LH is now 10.38, given the latest momentum, and Return on Invested Capital for the company is 6.09. Return on Equity for this stock inclined to 11.33, with Return on Assets sitting at 4.81. When it comes to the capital structure of this company, Laboratory Corporation of America Holdings [LH] has a Total Debt to Total Equity ratio set at 93.93. Additionally, LH Total Debt to Total Capital is recorded at 48.43, with Total Debt to Total Assets ending up at 39.39. Long-Term Debt to Equity for the company is recorded at 85.60, with the Long-Term Debt to Total Capital now at 44.14.
Reflecting on the efficiency of the workforce at the company, Laboratory Corporation of America Holdings [LH] managed to generate an average of $12,674 per employee. Receivables Turnover for the company is 5.94 with a Total Asset Turnover recorded at a value of 0.68.Laboratory Corporation of America Holdings’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.00 and a Current Ratio set at 1.10.
Earnings per share (EPS) analysis for Laboratory Corporation of America Holdings [LH] stock
With the latest financial reports released by the company, Laboratory Corporation of America Holdings posted 2.9/share EPS, while the average EPS was predicted by analysts to be reported at 2.85/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 1.80%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for LH. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Laboratory Corporation of America Holdings go to 8.44%.
Laboratory Corporation of America Holdings [LH]: Insider Ownership positions
There are presently around $15,718 million, or 93.20% of LH stock, in the hands of institutional investors. The top three institutional holders of LH stocks are: VANGUARD GROUP INC with ownership of 10,867,212, which is approximately -2.494% of the company’s market cap and around 0.40% of the total institutional ownership; BLACKROCK INC., holding 7,948,868 shares of the stock with an approximate value of $1.39 billion in LH stocks shares; and STATE STREET CORP, currently with $729.77 million in LH stock with ownership of nearly -2.804% of the company’s market capitalization.
Positions in Laboratory Corporation of America Holdings stocks held by institutional investors increased at the end of July and at the time of the July reporting period, where 390 institutional holders increased their position in Laboratory Corporation of America Holdings [NYSE:LH] by around 10,578,704 shares. Additionally, 387 investors decreased positions by around 9,693,491 shares, while 122 investors held positions by with 69,927,495 shares. The mentioned changes placed institutional holdings at 90,199,690 shares, according to the latest SEC report filing. LH stock had 130 new institutional investments in for a total of 3,509,380 shares, while 86 institutional investors sold positions of 1,565,344 shares during the same period.